Tissue-Specific Sample Dilution: An Important Parameter to Optimise Prior to Untargeted LC-MS Metabolomics

Abstract

When developing a sample preparation protocol for LC–MS untargeted metabolomics of a new sample matrix unfamiliar to the laboratory, selection of a suitable injection concentration is rarely described. Here we developed a simple workflow to address this issue prior to untargeted LC–MS metabolomics using pig adipose tissue and liver tissue. Bi-phasic extraction was performed to enable simultaneous optimisation of parameters for analysis of both lipids and polar extracts. A series of diluted pooled samples were analysed by LC–MS and used to evaluate signal linearity. Suitable injected concentrations were determined based on both the number of reproducible features and linear features. With our laboratory settings, the optimum concentrations of tissue mass to reconstitution solvent of liver and adipose tissue lipid fractions were found to be 125 mg/mL and 7.81 mg/mL respectively, producing 2811 (ESI+) and 4326 (ESI−) linear features from liver, 698 (ESI+) and 498 (ESI−) linear features from adipose tissue. For analysis of the polar fraction of both tissues, 250 mg/mL was suitable, producing 403 (ESI+) and 235 (ESI−) linear features from liver, 114 (ESI+) and 108 (ESI−) linear features from adipose tissue. Incorrect reconstitution volumes resulted in either severe overloading or poor linearity in our lipid data, while too dilute polar fractions resulted in a low number of reproducible features (<50) compared to hundreds of reproducible features from the optimum concentration used. Our study highlights on multiple matrices and multiple extract and chromatography types, the critical importance of determining a suitable injected concentration prior to untargeted LC–MS metabolomics, with the described workflow applicable to any matrix and LC–MS system.

Metabolomic signatures for visceral adiposity and dysglycaemia in Asian Chinese and Caucasian European adults: the cross-sectional TOFI_Asia study

“…On the day of instrumental analysis, dried polar and lipid extracts were reconstituted in 200 µL acetonitrile:H 2 O (50:50, v/v) and modified Folch solution (CHCl 3 :MeOH:H 2 O, 66:33:1, v/v/v) containing pre-dissolved 0.01% 16:0 d 31 -18:1-PE internal standard [0.01% (%w/v)] for polar metabolite and lipid analysis respectively. The reconstitution volume was determined using a previously described workflow [ 39 ].…”

“…On the day of instrumental analysis, dried polar and lipid extracts were respectively. The reconstitution volume was determined using a previously described workflow [39].…”

Dried Blood Spot (DBS) Methodology Study for Biomarker Discovery in Lysosomal Storage Disease (LSD)

“…There are numerous studies conducted on the factors that contribute to the stability of the metabolites in human samples [3]. Still, there is a big gap between the number of stability studies performed on DBS samples and non-DBS samples, such as serum, plasma, urine, and tissue [28].…”

n-Butylamine for Improving the Efficiency of Untargeted Mass Spectrometry Analysis of Plasma Metabolite Composition

“…It should be noted that the increase in the overall number of registered mass peaks in spectra does not mean a proportional increase in the number of detected metabolites. Many of those registered in spectra mass peaks are isotopic masses, various adducts of metabolites, results of metabolite fragmentation, and so forth, which do not possess any biological information [40]. However, the increase in the total number of detected mass peaks also enables an increase in the number of “captured” metabolites.…”